What the U.S. Supreme Court’s latest decision on skinny labeling means for branded drug manufacturers What the U.S. Supreme Court’s latest decision on skinny labeling means for branded drug manufacturers by Dana Severance and Alexander Wharton at Womble Bond Dickinson Read the update June 12, 2026 Morning Brief